↓ Skip to main content

DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci

Overview of attention for article published in Annals of Clinical Microbiology and Antimicrobials, October 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
17 X users

Citations

dimensions_citation
76 Dimensions

Readers on

mendeley
89 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
Published in
Annals of Clinical Microbiology and Antimicrobials, October 2019
DOI 10.1186/s12941-019-0329-6
Pubmed ID
Authors

Carmen Hidalgo-Tenorio, David Vinuesa, Antonio Plata, Pilar Martin Dávila, Simona Iftimie, Sergio Sequera, Belén Loeches, Luis Eduardo Lopez-Cortés, Mari Carmen Fariñas, Concepción Fernández-Roldan, Rosario Javier-Martinez, Patricia Muñoz, Maria del Mar Arenas-Miras, Francisco Javier Martínez-Marcos, Jose Maria Miró, Carmen Herrero, Elena Bereciartua, Samantha E. De Jesus, Juan Pasquau

X Demographics

X Demographics

The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 89 100%

Demographic breakdown

Readers by professional status Count As %
Other 13 15%
Student > Ph. D. Student 7 8%
Researcher 7 8%
Student > Master 7 8%
Student > Doctoral Student 6 7%
Other 19 21%
Unknown 30 34%
Readers by discipline Count As %
Medicine and Dentistry 32 36%
Pharmacology, Toxicology and Pharmaceutical Science 9 10%
Biochemistry, Genetics and Molecular Biology 3 3%
Business, Management and Accounting 3 3%
Economics, Econometrics and Finance 3 3%
Other 6 7%
Unknown 33 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2022.
All research outputs
#3,300,221
of 25,010,497 outputs
Outputs from Annals of Clinical Microbiology and Antimicrobials
#65
of 669 outputs
Outputs of similar age
#66,223
of 363,607 outputs
Outputs of similar age from Annals of Clinical Microbiology and Antimicrobials
#3
of 14 outputs
Altmetric has tracked 25,010,497 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 669 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,607 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.